Human large granular lymphocytes induce immunoglobulin synthesis after bone marrow transplantation. 1987

M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice

Following T cell-depleted bone marrow transplantation, helper T cell numbers remain depressed for some months. Nonetheless, functional B cells can be adoptively transferred to the recipients of such grafts, where they continue to secrete antibody. We now show that immunoglobulin production by these transferred B cells is induced by activated large granular lymphocytes (LGL) which circulate in the recipients in substantial numbers during the immediate post-transplant period. The LGL are CD3 negative and therefore provide help in an antigen-unlinked manner. Helper effects for autologous (donor) B cells are augmented by the addition of anti-LFA-2 (anti-CD2) which appears to act by blocking recruitment of LGL inhibitory to developing B cells. In contrast antibody to the beta chain of LFA-1, which effectively reduces natural killer activity of LGL, does not influence their helper function. The peripheral blood LGL fraction thus contains both helper and cytotoxic activity, which can be distinguished by appropriate monoclonal antibodies.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008211 Lymphocyte Cooperation T-cell enhancement of the B-cell response to thymic-dependent antigens. Cooperation, Lymphocyte,Cooperations, Lymphocyte,Lymphocyte Cooperations
D008212 Lymphocyte Depletion Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Depletion, Lymphocyte
D008297 Male Males
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell

Related Publications

M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
September 1987, Journal of clinical immunology,
M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
May 1987, The American journal of medicine,
M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
December 2001, Bone marrow transplantation,
M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
March 1987, British journal of haematology,
M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
December 1997, Arquivos de neuro-psiquiatria,
M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
February 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
September 1986, Transplantation,
M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
October 2003, American journal of clinical pathology,
M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
May 1999, Haematologica,
M K Brenner, and A Vyakarnam, and J E Reittie, and J Z Wimperis, and J P Grob, and A V Hoffbrand, and H G Prentice
October 1978, Problemy gematologii i perelivaniia krovi,
Copied contents to your clipboard!